Press releases

• Jul 3, 2019Calliditas has resolved on a directed share issue in the amount of 3.5 million shares, raising proceeds of approximately SEK 210 million
• Jul 2, 2019Calliditas considers a directed share issue
• Jun 10, 2019Calliditas Therapeutics and Everest Medicines Enter into an Agreement to Develop and Commercialize Nefecon for IgA Nephropathy in Greater China and Singapore

All press releases

Interim report January 1 – March 31, 2019

On May 8, 2019 Calliditas Therapeutics published its business update for Interim report January 1 – March 31, 2019.

• Report
• Presentation
• Audio cast

Read the report

Calendar

• Aug 15, 2019Interim report for the period 1 January – 30 June 2019
• Nov 14, 2019Interim report for the period 1 January – 30 September 2019
• Feb 14, 2020Year-end report for the period 1 January – 31 December 2019

All events